OAD-MS/MS for the Structural Identification of Double- Bond Positions in Lipids Associated with Alcohol Toxicity

OAD-MS/MS for Structural Identification of Lipid Double-Bond Positions in an Ethanol Toxicity Study

Significance of the topic

Accurate structural characterization of lipids—including fatty acyl chain length, degree of unsaturation and the precise positions of carbon–carbon double bonds—is critical in metabolomics and lipidomics because positional isomers can have distinct biological functions. Methods capable of assigning double-bond positions at scale improve biochemical interpretation of perturbations (e.g., drug or toxicant exposure) and increase confidence in candidate biomarkers. Oxygen Attachment Dissociation (OAD) MS/MS is a novel radical-driven fragmentation technique that selectively cleaves C=C bonds and complements conventional collision-induced dissociation (CID), enabling structural-level lipid annotation in untargeted studies.

Aims and study overview

The study applied OAD-MS/MS on a Shimadzu LCMS-9050 equipped with an OAD radical source to characterize unsaturated lipids that were previously flagged as significant in an untargeted UHPLC-CID-MS(/MS) metabolomics study of chronic ethanol exposure in mice. Tissue extracts (gut, liver, pancreas) from ethanol-exposed and control C57BL/6 mice were re-analysed to (i) assign C=C double-bond positions and regiochemistry (sn-1 vs sn-2), (ii) improve identification confidence using simultaneous OAD and CID spectra, and (iii) produce a curated list of structurally defined lipids that change with ethanol toxicity.

Methodology

Sample preparation and source material

• Tissue extracts (gut, liver, pancreas) from control and ethanol-exposed mice from a prior untargeted study were analysed to structurally resolve previously annotated lipid features.

Chromatography and general LC conditions (summary)

• Instrument: Nexera X2 UHPLC with a C18 column (2.1 x 100 mm, 1.7 µm) maintained at 50 °C.
• Mobile phases: water + 0.1% formic acid (A) and acetonitrile + 0.1% formic acid (B).
• Flow: 0.4 mL/min with a gradient from 2% to 90–100% B (curvi-linear gradient, total run ~35 min).
• Injection volumes: 1 µL (positive ESI) and 2 µL (negative ESI); autosampler at 4 °C.

Mass spectrometry and OAD radical generation (summary)

• MS platform: Shimadzu LCMS-9050 QTOF with an OAD Radical Source I.
• Ionization: ESI in both positive and negative modes (±3–4 kV); interface/heating block/detector temperatures ~300–400 °C.
• OAD radical generation: microwave discharge of water vapor produces atomic oxygen (O) and hydroxyl radicals (OH•) introduced into the collision/cell region (via an inductively coupled plasma through a quartz tube). Neutral radicals interact with precursor ions to selectively oxidize/dissociate C=C bonds.
• Acquisition: TOF-MS full scan m/z 60–1250; data-dependent acquisition (DDA) MS/MS with simultaneous CID and OAD-MS/MS; collision energy spread used (e.g., 6–30 V or wider CE spread for CID 5–55 V); precursor isolation widths adjusted per mode (e.g., 0.8 Da ESI+ / 3 Da ESI–).

Data processing

• Software: LabSolutions Insight Explore and MS-DIAL with an OAD-specific database for automated matching of OAD fragmentation patterns.
• Strategy: DDA spectra acquired in both polarities were interrogated to identify OAD-specific neutral losses and fragment ions diagnostic of double-bond positions. Assignments reported using both omega (n-) and delta (Δ) nomenclature.

Used instrumentation

• Nexera X2 UHPLC system with C18 column (2.1 × 100 mm, 1.7 µm).
• LCMS-9050 QTOF mass spectrometer with OAD Radical Source I (microwave discharge radical generator and ICP/quartz delivery into collision cell).
• Software tools: LabSolutions Insight Explore and MS-DIAL (with OAD database).

Main results and discussion

• OAD-MS/MS provided C=C positional information that was not accessible from CID alone. Simultaneous acquisition of OAD and CID spectra in positive and negative ionization modes yielded complementary information required for structural-level annotation (double-bond positions and sn-regioisomers).
• Example—LPC 22:5 isomers: Four retention-time resolved LPC 22:5 components were present; CID (positive/negative) permitted acyl-chain identification and sn-1/sn-2 assignment to some extent, but could not discriminate among certain retention time-separated isomers. OAD-MS/MS produced position-specific fragments that enabled identification of LPC 22:5(n-3,6,9,12,15) and LPC 22:5(n-6,9,12,15,18) at both sn-1 and sn-2 positions, resolving four separate components.
• Tissue-specific responses: Structural characterisation by OAD-MS/MS confirmed that ethanol exposure induced largely tissue-specific lipid alterations. Notable trends included increases in lipids containing omega-6 linoleic-type motifs (e.g., PC species with 18:2 n-6,9) and decreases in highly polyunsaturated phospholipids (species with ≥4 double bonds).
• Confidence level: The original untargeted annotations were MSI level 2 (match to literature/external spectra). OAD-enabled positional assignments raise the structural detail and confidence for unsaturated lipids by providing direct evidence for double-bond positions and regioisomer identity.

Benefits and practical applications

• Enhanced structural resolution: OAD complements CID to directly localize C=C positions, enabling differentiation of positional isomers and sn-regioisomers that otherwise co-elute or produce ambiguous CID spectra.
• Compatibility and safety: OAD uses neutral radicals generated from water vapor and is described as less hazardous than some alternative radical-based approaches while delivering efficient fragmentation, including for singly charged precursors.
• Workflow integration: Simultaneous CID and OAD acquisition and automated matching in MS-DIAL accelerate identification in untargeted workflows and enable retrospective re-analysis of previously acquired datasets.
• Application domains: Mechanistic lipidomics, biomarker discovery, toxicology (e.g., ethanol effects), nutritional studies, and any context where precise lipid structure is required for interpretation.

Future trends and potential uses

• Broader adoption in lipidomics pipelines: Integration of OAD spectral libraries into mainstream databases and routine MS-DIAL workflows will support larger-scale positional lipidomics studies.
• Computational support: Advances in computational mass spectrometry, machine learning, and expanded spectral libraries can automate interpretation of OAD patterns and propagate confidence scores across studies.
• Targeted quantitative assays: Structural assignments provided by OAD can guide development of targeted MRM/SRM or PRM assays to quantify specific positional isomers for biomarker validation.
• Extension to other classes and ion types: Continued method development to optimize OAD for neutral lipids, sphingolipids, and other challenging classes and for multiply charged species.
• Standardization and reporting: Adoption of OAD-informed reporting conventions will support harmonization with MSI levels and enable comparability between laboratories.

Conclusion

OAD-MS/MS implemented on a QTOF platform enables direct localization of C=C double bonds and, when combined with CID, allows confident structural identification of lipid isomers and regioisomers observed in untargeted studies. In the ethanol toxicity study, OAD resolved isomeric LPC/PC species and provided tissue-specific structural insights (notably modulation of omega-6 containing PCs and depletion of highly polyunsaturated phospholipids). The approach enhances identification confidence and supports mechanistic interpretation and biomarker prioritization in lipidomics.

References

1. Uchino H., Tsugawa T., Takahashi H., Arita M. Computational mass spectrometry accelerates C = C position-resolved untargeted lipidomics using oxygen attachment dissociation. Communications Chemistry. 2022;5(1).
2. Han X., Gross R.W. Structural Determination of Lysophospholipid Regioisomers by Electrospray Ionization Tandem Mass Spectrometry. Journal of the American Chemical Society. 1996;118(2):451–457.
3. Spicer R., Salek R., Steinbeck C. A decade after the metabolomics standards initiative it's time for a revision. Scientific Data. 2017;4:170138.